NLRP3-IN-69
NLRP3-IN-69 (Compound 23) inhibits the activation of NF-κB p65 and the formation of NLRP3 inflammasome. NLRP3-IN-69 inhibits LPS (HY-D1056) -induced overexpression of IL-1β, iNOS and COX-2, inhibits NO generation (IC50=5.66 μM), thereby exhibiting anti-inflammatory activity[1].
Product Specifications
UNSPSC
12352005
Target
COX; Interleukin Related; NF-κB; NO Synthase; NOD-like Receptor (NLR)
Related Pathways
Immunology/Inflammation; NF-κB
Field of Research
Inflammation/Immunology
Smiles
COC1=C(OC)C(OC)=CC(/C=C/C(OC2=CC(C=CC([C@@H](C(O)=O)C)=C3)=C3C=C2)=O)=C1
Molecular Formula
C25H24O7
Molecular Weight
436.45
References & Citations
[1]Yu J, et al., Novel Cinnamic Acid Derivatives Containing Naproxen as NLRP3 Inhibitors: Synthesis and Evaluation of Their Biological Activity. Chem Biodivers. 2024 Dec 29:e202402700.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-170836/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[3027608-60-9]
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6208871-01 0.1 mL
TAZ (tafazzin, BTHS, CMD3A, EFE, EFE2, FLJ27390, G4.5, LVNCX, Taz1, XAP-2) (MaxLight 490)
Ask
View Details